#BEGIN_DRUGCARD DB04711

# AHFS_Codes:
Not Available

# ATC_Codes:
V08AC04

# Absorption:
Not Available

# Biotransformation:
Hepatic.

# Brand_Mixtures:
Not Available

# Brand_Names:
Bilignost
Bilignostum
Biligrafin
Cholografin
Cholospect
Transbilix

# CAS_Registry_Number:
606-17-7

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H14I6N2O6

# Chemical_IUPAC_Name:
3-{5-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]pentanamido}-2,4,6-triiodobenzoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:27 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Iodipamide is a water-soluble radiographic contrast media for cholecystography and intravenous cholangiography. [PubChem]

# Dosage_Forms:
Injection, solution	Intravenous drip

# Drug_Category:
Contrast Media

# Drug_Interactions:
Not Available

# Drug_Reference:
925927	Lin SK, Moss AA, Riegelman S: Iodipamide kinetics: capacity-limited biliary excretion with simultaneous pseudo-first-order renal excretion. J Pharm Sci. 1977 Dec;66(12):1670-4.

# Drug_Type:
Approved
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
460 mg/L (at 20 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Iodipamide

# HET_ID:
IDB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34)

# InChI_Key:
InChIKey=FFINMCNLQNTKLU-UHFFFAOYSA-N

# Indication:
Iodipamide is used as a contrast agent for cholecystography and intravenous cholangiography.

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
D01774

# LIMS_Drug_ID:
4711

# Mechanism_Of_Action:
Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these iodinated organic compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. Iodipamide's primary excretion through the hepato-biliary system and concentration in bile allows visualization of the gallbladder and biliary ducts.

# Melting_Point:
307 dec °C

# Molecular_Weight_Avg:
1139.7618

# Molecular_Weight_Mono:
1139.51199671

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA164745532

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.42

# Predicted_LogS:
-5.6

# Predicted_Water_Solubility:
3.06e-03 g/l

# Primary_Accession_No:
DB04711

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3739

# PubChem_Substance_ID:
46507320

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=C(I)C(NC(=O)CCCCC(=O)NC2=C(I)C=C(I)C(C(O)=O)=C2I)=C(I)C=C1I

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
3,3'-[(1,6-dioxohexane-1,6-diyl)diimino]bis(2,4,6-triiodobenzoic acid)
Adipiodona [INN-Spanish]
Adipiodone
Adipiodonum [INN-Latin]
IDB
Iodipamic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Ionic radiocontrast agents like iodipamide are cytotoxic to renal cells. The toxic effects include apoptosis, cellular energy failure, disruption of calcium homeostasis, and disturbance of tubular cell polarity, and are thought to be linked to oxidative stress. Acute IV LD50 is 5000 mg/kg in rat, 3195 mg/kg in mouse, and 1200 mg/kg in dog.

# Update_Date:
2013-02-08 16:23:37 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

#END_DRUGCARD DB04711
